@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP885621.RAm_uISYk4IefY6zz1vFhlYZVQa-Efq_xPepHT8js7428130_head { this: np:hasAssertion dgn-np:NP885621.RAm_uISYk4IefY6zz1vFhlYZVQa-Efq_xPepHT8js7428130_assertion; np:hasProvenance dgn-np:NP885621.RAm_uISYk4IefY6zz1vFhlYZVQa-Efq_xPepHT8js7428130_provenance; np:hasPublicationInfo dgn-np:NP885621.RAm_uISYk4IefY6zz1vFhlYZVQa-Efq_xPepHT8js7428130_publicationInfo; a np:Nanopublication . dgn-np:NP885621.RAm_uISYk4IefY6zz1vFhlYZVQa-Efq_xPepHT8js7428130_assertion a np:Assertion . dgn-np:NP885621.RAm_uISYk4IefY6zz1vFhlYZVQa-Efq_xPepHT8js7428130_provenance a np:Provenance . dgn-np:NP885621.RAm_uISYk4IefY6zz1vFhlYZVQa-Efq_xPepHT8js7428130_publicationInfo a np:PublicationInfo . } dgn-np:NP885621.RAm_uISYk4IefY6zz1vFhlYZVQa-Efq_xPepHT8js7428130_assertion { miriam-gene:27087 a ncit:C16612 . lld:C0006826 a ncit:C7057 . dgn-gda:DGNc88709d3d06bd3cefea2c955c2537c77 sio:SIO_000628 miriam-gene:27087, lld:C0006826; a sio:SIO_001121 . } dgn-np:NP885621.RAm_uISYk4IefY6zz1vFhlYZVQa-Efq_xPepHT8js7428130_provenance { dgn-np:NP885621.RAm_uISYk4IefY6zz1vFhlYZVQa-Efq_xPepHT8js7428130_assertion dcterms:description "[Many data suggest the deep involvement of the substance P (SP)/neurokinin (NK)-1 receptor system in cancer: (1) Tumor cells express SP, NK-1 receptors and mRNA for the tachykinin NK-1 receptor; (2) Several isoforms of the NK-1 receptor are expressed in tumor cells; (3) the NK-1 receptor is involved in the viability of tumor cells; (4) NK-1 receptors are overexpressed in tumor cells in comparison with normal ones and malignant tissues express more NK-1 receptors than benign tissues; (5) Tumor cells expressing the most malignant phenotypes show an increased percentage of NK-1 receptor expression; (6) The expression of preprotachykinin A is increased in tumor cells in comparison with the levels found in normal cells; (7) SP induces the proliferation and migration of tumor cells and stimulates angiogenesis by increasing the proliferation of endothelial cells; (8) NK-1 receptor antagonists elicit the inhibition of tumor cell growth; (9) The specific antitumor action of NK-1 receptor antagonists on tumor cells occurs through the NK-1 receptor; (10) Tumor cell death is due to apoptosis; (11) NK-1 receptor antagonists inhibit the migration of tumor cells and neoangiogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:23933301; prov:wasDerivedFrom dgn-void:befree-20150227; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-20150227 pav:importedOn "2015-02-27"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP885621.RAm_uISYk4IefY6zz1vFhlYZVQa-Efq_xPepHT8js7428130_publicationInfo { this: dcterms:created "2015-08-25T14:46:39+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetv3.0rdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v3.0.0.0" . dgn-void:disgenetv3.0rdf pav:version "v3.0.0" . }